Skip to content
Peptide blend

What is the KLOW peptide (KLOW stack)?

KLOW peptide explained in plain English: what it is, what the research shows, side effects, legal status and dosage. There is no validated human dose, and this page doesn't invent one. Also called KLOW stack, KLOW blend.

KLOW peptide is a seller's name for a mix of research peptides that are not approved for human use, and the mix itself has never been tested in people. This page is educational.

What is the KLOW peptide?

The KLOW peptide, also sold as the “KLOW stack” or “KLOW blend,” is a vial that mixes four research peptides: GHK-Cu, KPV, BPC-157 and TB-500. It is a seller’s product name, not a single peptide or a medicine.

It is the Glow peptide blend with KPV added; the K stands for KPV. Most versions contain mostly GHK-Cu, but recipes vary between sellers.

What is the KLOW peptide used for?

KLOW is marketed for healing and recovery, skin, and inflammation. Sellers combine the claims for each ingredient: skin support from GHK-Cu, tissue repair from BPC-157 and TB-500, and calmer inflammation from KPV.

Those are claims about the separate ingredients, mostly from animal studies. Nobody has tested whether the four together do any of it in people.

What are the claimed KLOW peptide benefits?

The claimed benefits are faster recovery from injuries, less inflammation, better gut health and better-looking skin. The evidence behind each part is thin:

  • GHK-Cu: small human studies as a skin cream only; injections untested in people.
  • KPV: studied in cells and mice with colitis; no human trials.
  • BPC-157: mostly animal studies, plus three small human pilot studies.
  • TB-500: no published human trials.

No study has tested the KLOW blend itself.

KLOW peptide side effects and risks

The side effects of the blend are unknown. Risks include reactions to any of the four peptides, unknown long-term effects, and the quality problems common to products sold online: wrong amounts, impurities or contamination.

None of its ingredients is approved for injection in people. The FDA’s 2026 compounding changes applied to single peptides, not to blends.

BPC-157 and TB-500 are also banned in sport by the World Anti-Doping Agency.

How do you mix a blend vial?

A blend vial is mixed with bacteriostatic water like any other peptide powder, but a single dose then contains all four peptides in fixed proportions. Because the amounts vary by seller, check the vial label, and see the reconstitution guide for the steps.

See the dosage section below for what is known about doses, with sources.

KLOW peptide dosage

The KLOW blend has never been tested in people, and its recipe varies by seller, so there is no validated human dose for the blend or its parts.

There is no approved or validated human dose. This site does not repeat doses from forums, sellers or animal studies.

Medical disclaimer: this dosage information is for education only and comes from the source shown for each row. It is not medical advice and not a recommendation for you. Only a licensed prescriber who knows your health can decide whether KLOW peptide is right for you and at what dose. Don't start, change or stop a medicine based on this page, and don't use research peptides or unapproved drugs based on trial doses.

Frequently asked questions

What is KLOW peptide used for?

Sellers market it for healing, recovery, skin and inflammation, adding up the claims made for its four ingredients. None of those uses has been tested for the blend in people.

What are the KLOW peptide benefits?

The claimed benefits are faster healing, calmer inflammation and better skin. They come from animal and lab studies of each ingredient on its own; the mix itself has no studies.

What is in KLOW?

Four peptides: GHK-Cu, KPV, BPC-157 and TB-500. Most versions are mostly GHK-Cu with smaller, equal amounts of the other three, but recipes vary.

Is KLOW the same as GLOW?

Almost. KLOW is the GLOW blend (GHK-Cu, BPC-157 and TB-500) with KPV added. The K stands for KPV.

Sources

  1. FDA, Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks
  2. Dalmasso et al. (2008), PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation, Gastroenterology
  3. McGuire et al. (2025), Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing, Current Reviews in Musculoskeletal Medicine
  4. PolitiFact (2026), What are peptides, and are they safe?

Last updated .

More peptide guides and calculators